vs
爱德华生命科学（EW）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Rivian Automotive, Inc.的1.3倍（$1.6B vs $1.3B），爱德华生命科学净利率更高（23.1% vs -63.1%，领先86.2%），爱德华生命科学同比增速更快（16.7% vs -25.8%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs 3.3%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
EW vs RIVN — 直观对比
营收规模更大
EW
是对方的1.3倍
$1.3B
营收增速更快
EW
高出42.5%
-25.8%
净利率更高
EW
高出86.2%
-63.1%
两年增速更快
EW
近两年复合增速
3.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.3B |
| 净利润 | $380.7M | $-811.0M |
| 毛利率 | 78.0% | 9.3% |
| 营业利润率 | 1.8% | -64.8% |
| 净利率 | 23.1% | -63.1% |
| 营收同比 | 16.7% | -25.8% |
| 净利润同比 | 6.8% | -9.0% |
| 每股收益（稀释后） | $0.66 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRIVN
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.6B | $1.6B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.4B | $874.0M | ||
| Q2 24 | $1.4B | $1.2B |
净利润EWRIVN
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $-811.0M | ||
| Q3 25 | $291.1M | $-1.2B | ||
| Q2 25 | $333.2M | $-1.1B | ||
| Q1 25 | $358.0M | $-545.0M | ||
| Q4 24 | $385.6M | $-744.0M | ||
| Q3 24 | $3.1B | $-1.1B | ||
| Q2 24 | $366.3M | $-1.5B |
毛利率EWRIVN
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | 9.3% | ||
| Q3 25 | 77.8% | 1.5% | ||
| Q2 25 | 77.5% | -15.8% | ||
| Q1 25 | 78.7% | 16.6% | ||
| Q4 24 | 78.9% | 9.8% | ||
| Q3 24 | 80.6% | -44.9% | ||
| Q2 24 | 79.9% | -38.9% |
营业利润率EWRIVN
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | -64.8% | ||
| Q3 25 | 19.8% | -63.1% | ||
| Q2 25 | 26.8% | -85.5% | ||
| Q1 25 | 27.9% | -52.8% | ||
| Q4 24 | 22.6% | -38.1% | ||
| Q3 24 | 25.9% | -133.8% | ||
| Q2 24 | 26.8% | -118.7% |
净利率EWRIVN
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | -63.1% | ||
| Q3 25 | 18.7% | -75.3% | ||
| Q2 25 | 21.7% | -85.7% | ||
| Q1 25 | 25.3% | -44.0% | ||
| Q4 24 | 27.8% | -42.9% | ||
| Q3 24 | 226.7% | -125.9% | ||
| Q2 24 | 26.7% | -125.8% |
每股收益（稀释后）EWRIVN
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $-0.66 | ||
| Q3 25 | $0.50 | $-0.96 | ||
| Q2 25 | $0.56 | $-0.97 | ||
| Q1 25 | $0.61 | $-0.48 | ||
| Q4 24 | $0.65 | $-0.67 | ||
| Q3 24 | $5.13 | $-1.08 | ||
| Q2 24 | $0.61 | $-1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $6.1B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $4.6B |
| 总资产 | — | $14.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $6.1B | ||
| Q3 25 | $3.8B | $7.1B | ||
| Q2 25 | $4.1B | $7.5B | ||
| Q1 25 | $3.9B | $7.2B | ||
| Q4 24 | $4.0B | $7.7B | ||
| Q3 24 | $4.4B | $6.7B | ||
| Q2 24 | $2.0B | $7.9B |
总债务EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $5.5B |
股东权益EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $4.6B | ||
| Q3 25 | $10.2B | $5.1B | ||
| Q2 25 | $10.5B | $6.1B | ||
| Q1 25 | $10.1B | $6.2B | ||
| Q4 24 | $10.0B | $6.6B | ||
| Q3 24 | $9.5B | $5.9B | ||
| Q2 24 | $7.4B | $6.8B |
总资产EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $14.9B | ||
| Q3 25 | $13.3B | $15.2B | ||
| Q2 25 | $13.5B | $15.6B | ||
| Q1 25 | $13.0B | $15.5B | ||
| Q4 24 | $13.1B | $15.4B | ||
| Q3 24 | $13.0B | $14.3B | ||
| Q2 24 | $10.1B | $15.4B |
负债/权益比EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.1B |
| 自由现金流率自由现金流/营收 | — | -89.0% |
| 资本支出强度资本支出/营收 | — | 36.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.5B |
8季度趋势，按日历期对齐
经营现金流EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $-681.0M | ||
| Q3 25 | $573.7M | $26.0M | ||
| Q2 25 | $290.2M | $64.0M | ||
| Q1 25 | $280.4M | $-188.0M | ||
| Q4 24 | $-127.5M | $1.2B | ||
| Q3 24 | $351.8M | $-876.0M | ||
| Q2 24 | $371.5M | $-754.0M |
自由现金流EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $-1.1B | ||
| Q3 25 | $516.2M | $-421.0M | ||
| Q2 25 | $240.9M | $-398.0M | ||
| Q1 25 | $224.4M | $-526.0M | ||
| Q4 24 | $-177.3M | $856.0M | ||
| Q3 24 | $299.9M | $-1.2B | ||
| Q2 24 | $286.1M | $-1.0B |
自由现金流率EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | -89.0% | ||
| Q3 25 | 33.2% | -27.0% | ||
| Q2 25 | 15.7% | -30.5% | ||
| Q1 25 | 15.9% | -42.4% | ||
| Q4 24 | -12.8% | 49.4% | ||
| Q3 24 | 22.1% | -131.9% | ||
| Q2 24 | 20.9% | -89.6% |
资本支出强度EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 36.0% | ||
| Q3 25 | 3.7% | 28.7% | ||
| Q2 25 | 3.2% | 35.5% | ||
| Q1 25 | 4.0% | 27.3% | ||
| Q4 24 | 3.6% | 18.9% | ||
| Q3 24 | 3.8% | 31.7% | ||
| Q2 24 | 6.2% | 24.4% |
现金转化率EWRIVN
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | -0.33× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
